{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:04:14Z","timestamp":1788285854409,"version":"build-2803163510"},"reference-count":52,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Human papillomavirus (HPV) vaccines based on L1 virus-like particles (VLPs) can prevent HPV-induced genital neoplasias, the precursors of cervical cancer. However, most cervical cancers occur in developing countries, where the implementation of expensive vaccines requiring multiple injections will be difficult. A live\n            <jats:italic>Salmonella<\/jats:italic>\n            -based vaccine could be a lower-cost alternative. We previously demonstrated that high HPV type 16 (HPV16)-neutralizing titers are induced after a single oral immunization of mice with attenuated\n            <jats:italic>Salmonella enterica<\/jats:italic>\n            serovar Typhimurium strains expressing a codon-optimized version of HPV16 L1 (L1S). To allow the testing of this type of vaccine in women, we constructed a new L1-expressing plasmid, kanL1S, and tested kanL1S recombinants of three\n            <jats:italic>Salmonella enterica<\/jats:italic>\n            serovar Typhi vaccine strains shown to be safe in humans, i.e., Ty21a, the actual licensed typhoid vaccine, and two highly immunogenic typhoid vaccine candidates, Ty800 and CVD908-\n            <jats:italic>htrA<\/jats:italic>\n            . In an intranasal mouse model of\n            <jats:italic>Salmonella<\/jats:italic>\n            serovar Typhi infection, Ty21a kanL1S was unique in inducing HPV16-neutralizing antibodies in serum and genital secretions, while anti-\n            <jats:italic>Salmonella<\/jats:italic>\n            responses were similar to those against the parental Ty21a vaccine. Electron microscopy examination of Ty21a kanL1S lysates showed that L1 assembled in capsomers and capsomer aggregates but not well-ordered VLPs. Comparison to the neutralizing antibody response induced by purified HPV16 L1 VLP immunizations in mice suggests that Ty21a kanL1S may be an effective prophylactic HPV vaccine. Ty21a has been widely used against typhoid fever in humans with a remarkable safety record. These finds encourage clinical testing of Ty21a kanL1S as a combined typhoid fever\/cervical cancer vaccine with the potential for worldwide application.\n          <\/jats:p>","DOI":"10.1128\/cvi.00164-07","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T01:31:02Z","timestamp":1186623062000},"page":"1285-1295","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":57,"title":["<i>Salmonella enterica<\/i>\n            Serovar Typhi Ty21a Expressing Human Papillomavirus Type 16 L1 as a Potential Live Vaccine against Cervical Cancer and Typhoid Fever"],"prefix":"10.1128","volume":"14","author":[{"given":"Dominique","family":"Fraillery","sequence":"first","affiliation":[{"name":"Institute of Microbiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baud","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Yuk-Ying","family":"Pang","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schiller","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bobst","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Zosso","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc\u0327oise","family":"Ponci","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Nardelli-Haefliger","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.4.2135-2141.2000"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/mpat.1996.0099","volume":"22","year":"1997","unstructured":"Baker, S. J., C. Daniels, and R. Morona. 1997. Phop\/q regulated genes in Salmonella typhi\u2014identification of melittin sensitive mutants. Microb. Pathog.22:165-179.","journal-title":"Microb. Pathog."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.24.12596-12602.2002"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.10.8220-8229.1998"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.23.12901-12909.2004"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.7.3674-3679.1999"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","year":"2002","unstructured":"Bosch, F. X., A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah. 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol.55:244-265.","journal-title":"J. Clin. Pathol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.2.751-757.2004"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1574-695X.2000.tb01450.x","volume":"27","year":"2000","unstructured":"Bumann, D., C. Hueck, T. Aebischer, and T. F. Meyer. 2000. Recombinant live Salmonella spp. for human vaccination against heterologous pathogens. FEMS Immunol. Med. Microbiol.27:357-364.","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/jmbi.2000.4464","volume":"307","year":"2001","unstructured":"Chen, X. S., G. Casini, S. C. Harrison, and R. L. Garcea. 2001. Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16L1. J. Mol. Biol.307:173-182.","journal-title":"J. Mol. Biol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/viro.1996.0466","volume":"223","year":"1996","unstructured":"Christensen, N. D., J. Dillner, C. Eklund, J. J. Carter, G. C. Wipf, C. A. Reed, N. M. Cladel, and D. A. Galloway. 1996. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology223:174-184.","journal-title":"Virology"},{"key":"e_1_3_2_13_2","unstructured":"Attenuated Salmonella strains as live vectors for the expression of foreign antigens. 1990"},{"key":"e_1_3_2_14_2","unstructured":"Recombinant and synthetic vaccines. 1994"},{"key":"e_1_3_2_15_2","first-page":"26700","volume":"59","year":"1994","unstructured":"Federal Register. 1994. Secondary food additives permitted in food for human consumption; food additives permitted in feed and drinking water of animals; aminoglycoside 3\u2032-phophotransferase II, final rule. Fed. Regist.59:26700-26711.","journal-title":"Fed. Regist."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00227-7"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijmm.2004.07.010","volume":"294","year":"2004","unstructured":"Gentschev, I., G. Dietrich, S. Spreng, B. Beuhaus, E. Maier, R. Benz, W. Goebel, J. Fensterle, and U. R. Rapp. 2004. Use of the \u03b1-hemolysin secretion system of Escherichia coli for antigen delivery in the Salmonella typhi Ty21a vaccine strain. Int. J. Med. Microbiol.294:363-371.","journal-title":"Int. J. Med. Microbiol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","volume":"131","year":"1975","unstructured":"Germanier, R., and E. F\u00fcrer. 1975. Isolation and characterization of galE mutant Ty 21a of Salmonella typhi. A candidate strain for a live, oral typhoid vaccine. J. Infect. Dis.131:553-558.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnci\/93.4.284","volume":"93","year":"2001","unstructured":"Harro, C. D., Y. Y. Pang, R. B. Roden, A. Hildesheim, Z. Wang, M. J. Reynolds, T. C. Mast, R. Robinson, B. R. Murphy, R. A. Karron, J. Dillner, J. T. Schiller, and D. R. Lowy. 2001. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst.93:284-292.","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/173.6.1408","volume":"173","year":"1996","unstructured":"Hohmann, E. L., C. A. Oletta, K. P. Killeen, and S. I. Miller. 1996. Phop\/phoq-deleted Salmonella typhi (ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis.173:1408-1414.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/291238a0","volume":"291","year":"1981","unstructured":"Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature291:238-239.","journal-title":"Nature"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(91)90218-U"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.9.3279-3286.1995"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","volume":"89","year":"1992","unstructured":"Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and Y. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci.89:12180-12184.","journal-title":"Proc. Natl. Acad. Sci."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/76494","volume":"18","year":"2000","unstructured":"Lee, J. S., K. S. Shin, J. G. Pan, and C. J. Kim. 2000. Surface-displayed viral antigens on Salmonella carrier vaccine. Nat. Biotechnol.18:645-648.","journal-title":"Nat. Biotechnol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","volume":"17","year":"1999","unstructured":"Levine, M. M., C. Ferreccio, P. Abrego, M. O. San, E. Ortiz, and S. Cryz. 1999. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine17(Suppl. 2):S22-S27.","journal-title":"Vaccine"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S1286-4579(01)01487-3","volume":"3","year":"2001","unstructured":"Levine, M. M., C. O. Tacket, and M. B. Sztein. 2001. Host-Salmonella interaction: human trials. Microbes Infect.3:1271-1279.","journal-title":"Microbes Infect."},{"key":"e_1_3_2_28_2","unstructured":"Attenuated Salmonella as a live vector for expression of foreign antigens. 1997"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.9.5096-5106.2002"},{"key":"e_1_3_2_30_2","unstructured":"Papillomaviruses 2001"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI28607","volume":"116","year":"2006","unstructured":"Lowy, D., and J. Schiller. 2006. Prophylactic human papillomavirus vaccines. J. Clin. Investig.116:1167-1173.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.vaccine.2003.11.020","volume":"22","year":"2004","unstructured":"Metzger, W. G., E. Mansouri, M. Kronawitter, S. Diescher, M. Soerensen, R. Hurwitz, D. Bumann, T. Aebischer, B. U. von Specht, and T. F. Meyer. 2004. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar Typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine22:2273-2277.","journal-title":"Vaccine"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1073\/pnas.86.13.5054","volume":"86","year":"1989","unstructured":"Miller, S. I., A. M. Kukral, and J. J. Mekalanos. 1989. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. USA86:5054-5058.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.172.5.2485-2490.1990"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1016\/j.vaccine.2005.02.019","volume":"23","year":"2005","unstructured":"Nardelli-Haefliger, D., F. Lurati, D. Wirthner, F. Spertini, J. T. Schiller, D. R. Lowy, F. Ponci, and P. De Grandi. 2005. Immune responses induced by lower airway mucosal immunization with a human papillomavirus type 16 virus-like particle vaccine. Vaccine23:3634-3641.","journal-title":"Vaccine"},{"key":"e_1_3_2_36_2","first-page":"9609","volume":"74","year":"1999","unstructured":"Nardelli-Haefliger, D., R. Roden, C. Balmelli, A. Potts, J. Schiller, and P. De Grandi. 1999. Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice. J. Virol.74:9609-9613.","journal-title":"J. Virol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.8.3328-3336.1997"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djg018","volume":"95","year":"2003","unstructured":"Nardelli-Haefliger, D., D. Wirthner, J. Schiller, D. R. Lowy, A. Hildesheim, F. Ponci, and P. De Grandi. 2003. Specific antibody levels at the cervix during the menstrual-cycle of women vaccinated with human papillomavirus 16 virus-like particles. J. Natl. Cancer Inst.95:1128-1137.","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.12.5219-5224.1996"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","year":"2006","unstructured":"Parkin, D. M. 2006. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer118:3030-3044.","journal-title":"Int. J. Cancer"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0264-410X(02)00472-3","volume":"21","year":"2003","unstructured":"Pasetti, M. F., M. M. Levine, and M. B. Sztein. 2003. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine21:401-418.","journal-title":"Vaccine"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/S0264-410X(00)00142-0","volume":"18","year":"2000","unstructured":"Pasetti, M. F., T. E. Pickett, M. M. Levine, and M. B. Sztein. 2000. A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model. Vaccine18:3208-3213.","journal-title":"Vaccine"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2003.12.027","volume":"321","year":"2004","unstructured":"Pastrana, D. V., C. B. Buck, Y. Y. Pang, C. D. Thompson, P. E. Castle, P. C. FitzGerald, S. K. Kjaer, S., D. R. Lowy, and J. T. Schiller. 2004. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology321:205-216.","journal-title":"Virology"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.1.205-213.2000"},{"key":"e_1_3_2_45_2","first-page":"78","volume":"76","year":"2007","unstructured":"Revaz, V., R. Zurbriggen, C. Moser, Y. T. Schiller, F. Ponci, M. Babst, and D. Nardelli-Haefliger. 2007. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants Res.76:78-85.","journal-title":"Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants Res."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.7.6151-6154.1998"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.7.3611-3620.2002"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0065-3527(08)60041-X","volume":"41","year":"1992","unstructured":"Sch\u00f6del, F. 1992. Prospects for oral vaccination using recombinant bacteria expressing viral epitopes. Adv. Virus Res.41:409-446.","journal-title":"Adv. Virus Res."},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0264-410X(90)90010-J","volume":"8","year":"1990","unstructured":"Sch\u00f6del, F., G. Enders, M.-C. Jung, and H. Will. 1990b. Recognition of a hepatitis B virus nucleocapsid T-cell epitope expressed as a fusion protein with the subunit B of Escherichia coli heat labile enterotoxin in attenuated salmonellae. Vaccine8:569-572.","journal-title":"Vaccine"},{"key":"e_1_3_2_50_2","first-page":"146","volume":"97","year":"2001","unstructured":"Tacket, C. O., J. Galen, M. B. Sztein, G. Losonsky, T. L. Wyant, J. Nataro, S. S. Wasserman, R. Edelman, S. Chatfield, G. Dougan, and M. M. Levine. 2001. Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin. Immunol.97:146-153.","journal-title":"Clin. Immunol."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.2.452-456.1997"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.3.1196-1201.2000"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.8.4734-4741.2001"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00164-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00164-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:37:53Z","timestamp":1627591073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00164-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1128\/CVI.00164-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00164-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"2007-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-07-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}